CURX (Curanex Pharmaceuticals Inc Common Stock) Stock Analysis - Analyst Ratings

Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of May 21, 2026, CURX trades at $0.33 with a market cap of $8.53M and a P/E ratio of -1.91. CURX moved +0.00% today. Year to date, CURX is -9.92%; over the trailing twelve months it is flat. Its 52-week range spans $0.26 to $9.18. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CURX?

The average price target is $0.00.

CURX Key Metrics

Key financial metrics for CURX
MetricValue
Price$0.33
Market Cap$8.53M
P/E Ratio-1.91
EPS$-0.17
Dividend Yield0.00%
52-Week High$9.18
52-Week Low$0.26
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$-4.23M
Gross Margin0.00%

CURX Analyst Consensus

CURX analyst coverage data. Average price target: $0.00.

Latest CURX News

Common questions about CURX

What do analysts rate CURX?
The average price target is $0.00.
Does Rallies show CURX price targets?
Yes. Rallies tracks CURX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CURX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURX. It does not provide personalized investment advice.
CURX

CURX